Intracoronary Versus Intravenous Abciximab Bolus Administration Reply

被引：0
|
作者：
Desch, Steffen [1 ]
Eitel, Ingo [1 ]
Brosteanu, Oana [1 ]
Schuler, Gerhard [1 ]
Thiele, Holger [1 ]
机构：
[1] Univ Leipzig, Ctr Heart, Dept Internal Med Cardiol, D-04289 Leipzig, Germany
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2014年 / 63卷 / 13期
关键词：
PERCUTANEOUS CORONARY INTERVENTION; ELEVATION MYOCARDIAL-INFARCTION;
D O I：
10.1016/j.jacc.2013.11.036
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1342 / 1342
页数：1
相关论文
共 50 条
  • [1] Intracoronary Versus Intravenous Abciximab Bolus Administration
    De Rosa, Salvatore
    Caiazzo, Gianluca
    Torella, Daniele
    Indolfi, Ciro
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (13) : 1340 - 1341
  • [2] Mortality in intracoronary versus intravenous abciximab
    Gupta, Ankur
    Sharma, Yash Paul
    LANCET, 2012, 380 (9836): : 25 - 26
  • [3] Intracoronary versus Intravenous Administration of Abciximab in Patients with Acute Coronary Syndrome: A Meta-Analysis
    Wang, Jie-Ning
    Diao, Shu
    Tang, Yuan-Jun
    Hou, An-Ji
    Yuan, Hai-Bo
    Zheng, Yan
    Zhou, Yu-Hao
    PLOS ONE, 2013, 8 (02):
  • [4] Intracoronary versus intravenous abciximab administration in STEMI patients: overview of current status and open questions
    Kubica, Aldona
    Kozinski, Marek
    Navarese, Eliano Pio
    Grzesk, Grzegorz
    Goch, Aleksander
    Kubica, Jacek
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (11) : 2133 - 2144
  • [5] Platelet inhibition and GP IIb/IIIa receptor occupancy by intracoronary versus intravenous bolus administration of abciximab in patients with ST-elevation myocardial infarction
    Desch, Steffen
    Siegemund, Annelie
    Scholz, Ute
    Adam, Natalie
    Eitel, Ingo
    de Waha, Suzanne
    Fuernau, Georg
    Lurz, Philipp
    Wetzel, Sabrina
    Schuler, Gerhard
    Thiele, Holger
    CLINICAL RESEARCH IN CARDIOLOGY, 2012, 101 (02) : 117 - 124
  • [6] Rationale for intracoronary administration of abciximab
    Romagnoli, Enrico
    Burzotta, Francesco
    Trani, Carlo
    Biondi-Zoccai, Giuseppe G. L.
    Giannico, Floriana
    Crea, Filippo
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2007, 23 (01) : 57 - 63
  • [7] Rationale for intracoronary administration of abciximab
    Enrico Romagnoli
    Francesco Burzotta
    Carlo Trani
    Giuseppe G. L. Biondi-Zoccai
    Floriana Giannico
    Filippo Crea
    Journal of Thrombosis and Thrombolysis, 2007, 23 : 57 - 63
  • [8] Intracoronary vs intravenous abciximab in interventional cardiology: A reopened question?
    Zimarino, Marco
    Radico, Francesco
    Kristensen, Steen Dalby
    De Caterina, Raffaele
    VASCULAR PHARMACOLOGY, 2015, 73 : 8 - 10
  • [9] The Optimal Route of Administration of the Glycoprotein IIb/IIIa Receptor Antagonist Abciximab During Percutaneous Coronary Intervention; Intravenous Versus Intracoronary
    Iversen, Allan
    Galatius, Soren
    Jensen, Jan S.
    CURRENT CARDIOLOGY REVIEWS, 2008, 4 (04) : 293 - 299
  • [10] Intracoronary versus intravenous administration of abciximab during percutaneous coronary intervention for acute coronary syndrome: grading the evidence through a meta-analysis of randomized controlled trials
    Zhai, Chuan-Nan
    Zhang, Ying
    Liu, Yu-Jie
    Liu, Xian-Feng
    Zhang, Hao
    Ren, Zhi-Jing
    Cong, Hong-Liang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (07): : 14024 - 14035
12345